+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population



Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population



Clinical Genetics 73(3): 236-244



Mucolipidosis (ML) II (I-cell disease) is a lysosomal storage disorder caused by a deficiency of UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase. MLII is an autosomal recessive disease with a carrier rate estimated at 1/39 in Saguenay-Lac-Saint-Jean (SLSJ) (Quebec, Canada), which is the highest frequency documented worldwide. To identify the causing mutation, we sequenced GNPTAB exons in 27 parents of 16 MLII-deceased children from the SLSJ region as obligatory and potential carriers. We also performed a genealogical reconstruction for each parent to evaluate consanguinity levels and genetic contribution of ancestors. Our goal was to identify which parameters could explain the high MLII frequency observed in the SLSJ population. A single mutation (c.3503_3504delTC) was found in all obligatory carriers. In addition, 11 apparent polymorphisms were identified. The mutation was not detected in genomic DNA of 50 unrelated controls. Genealogical data show six founders (three couples) with a higher probability of having introduced the mutation in the population. The frequency of the mutation was increased as a consequence of this founder effect and of the resulting population structure. We suggest that c.3503_3504delTC is the allele causing MLII in the SLSJ population, and its high carrier rate is most likely explained by a founder effect.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 021380408

Download citation: RISBibTeXText

PMID: 18190596

DOI: 10.1111/j.1399-0004.2007.00954.x


Related references

Missense mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG. Human Mutation 27(8): 830-831, 2006

A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population. Bmc Medical Genetics 13: 72, 2012

Mutation analysis of GNPTAB gene in 24 japanese mucolipidosis II and. 2007

Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene. American Journal of Medical Genetics. Part a 158a(5): 1225-1228, 2012

A novel splice site mutation in the GNPTAB gene in an Iranian patient with mucolipidosis II α/β. Journal of Pediatric Endocrinology and Metabolism 29(8): 991-993, 2016

A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site. Human Mutation 24(6): 535, 2004

A novel compound heterozygous mutation of GNPTAB gene underlying a case with mucolipidosis type II α/β. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 36(6): 606-609, 2019

Mucolipidosis Ii Infants Presenting with Skeletal Deformities Mimicking Rickets and a new Mutation in Gnptab Gene. Genetic Counseling 27(3): 373-380, 2016

Exome sequencing for mucolipidosis III: Detection of a novel GNPTAB gene mutation in a patient with a very mild phenotype. Molecular Genetics and Metabolism Reports 2: 34-37, 2015

GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms. International Journal of Biochemistry and Cell Biology 92: 90-94, 2017

Molecular characterization of 22 novel UDP-N-acetylglucosamine-1-phosphate transferase alpha- and beta-subunit (GNPTAB) gene mutations causing mucolipidosis types IIalpha/beta and IIIalpha/beta in 46 patients. Human Mutation 30(11): E956, 2009

Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype. American Journal of Medical Genetics. Part A 137a(3): 235-240, 2005

Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. Clinical Genetics 87(6): 536-542, 2015

Loss of N-acetylglucosamine-1-phosphotransferase gamma subunit due to intronic mutation in GNPTG causes mucolipidosis type III gamma: Implications for molecular and cellular diagnostics. American Journal of Medical Genetics. Part a 152a(1): 124-132, 2010

Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB). Human Mutation 35(3): 368-376, 2014